$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000143774920011007 Filed on May 15, 2020

Income Statement

Concept	2020 Q1	2019 Q1	2018 Q4
Revenue	$1.811M	$1.916M	$3.766M
YoY Change	-5.46%	6.11%	69.63%
Cost Of Revenue	$527.3K	$618.7K	$1.864M
YoY Change	-14.78%	9.96%	88.33%
Gross Profit	$1.284M	$1.297M	$1.901M
YoY Change	-1.01%	4.37%	55.84%
Gross Profit Margin	70.89%	67.71%	50.49%
Selling, General & Admin	$2.748M	$2.109M	$1.897M
YoY Change	30.3%	-30.14%	-35.27%
% of Gross Profit	214.0%	162.58%	99.76%
Research & Development	$107.5K	$6.346K	$29.98K
YoY Change	1593.67%	-97.19%	-0.07%
% of Gross Profit	8.37%	0.49%	1.58%
Depreciation & Amortization	$37.22K	$26.05K	$26.17K
YoY Change	42.9%	-90.17%	-92.3%
% of Gross Profit	2.9%	2.01%	1.38%
Operating Expenses	$2.893M	$2.115M	$1.927M
YoY Change	36.75%	-34.8%	-35.13%
Operating Profit	-$1.609M	-$818.2K	-$25.41K
YoY Change	96.61%	-59.13%	-98.55%
Interest Expense	$110.00	$41.28K	$1.310K
YoY Change	-99.73%
% of Operating Profit
Other Income/Expense, Net	-$4.210K	-$2.264K	-$1.990K
YoY Change	85.95%	33.18%
Pretax Income	-$1.613M	-$779.2K	-$26.09K
YoY Change	106.98%	-61.06%	-98.5%
Income Tax	$250.00	$4.465K	$6.830K
% Of Pretax Income
Net Earnings	-$1.600M	-$782.8K	$179.9K
YoY Change	104.43%	-58.23%	-110.05%
Net Earnings / Revenue	-88.34%	-40.86%	4.78%
Basic Earnings Per Share	-$0.03	-$0.02
Diluted Earnings Per Share	-$0.03	-$0.02	$5.005K
COMMON SHARES
Basic Shares Outstanding	49.73M	40.53M
Diluted Shares Outstanding	49.73M	40.53M

Balance Sheet

Concept	2020 Q1	2019 Q1	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$766.0K	$2.740M	$743.4K
YoY Change	-72.04%	31.09%	-71.84%
Cash & Equivalents	$766.0K	$2.740M	$1.996M
Short-Term Investments
Other Short-Term Assets	$707.0K	$620.5K	$464.5K
YoY Change	13.93%	-61.22%	-70.03%
Inventory	$1.723M	$1.861M	$1.921M
Prepaid Expenses
Receivables	$1.290M	$1.513M	$1.978M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.261M	$7.314M	$5.856M
YoY Change	-28.07%	-33.55%	-51.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.96K	$77.87K	$82.56K
YoY Change	-61.52%	-32.58%	-41.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$24.15K	$17.36K	$26.88K
YoY Change	39.15%	-35.43%	0.0%
Total Long-Term Assets	$1.113M	$647.2K	$544.7K
YoY Change	72.03%	-114.05%	-84.9%
TOTAL ASSETS
Total Short-Term Assets	$5.261M	$7.314M	$5.856M
Total Long-Term Assets	$1.113M	$647.2K	$544.7K
Total Assets	$6.375M	$7.962M	$6.401M
YoY Change	-19.93%	24.38%	-59.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.444M	$1.199M	$1.059M
YoY Change	20.45%	-23.0%	8.34%
Accrued Expenses	$832.3K	$1.548M	$794.9K
YoY Change	-46.24%	-19.72%	-63.52%
Deferred Revenue		$50.00K	$100.0K
YoY Change			-94.2%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.240M	$5.219M	$4.873M
YoY Change	0.4%	-25.45%	-27.58%
LONG-TERM LIABILITIES
Long-Term Debt	$34.52K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$612.0K	$15.92K	$0.00
YoY Change	3744.35%	-98.86%	-100.0%
Total Long-Term Liabilities	$646.5K	$15.92K	$0.00
YoY Change	3961.18%	-98.86%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.240M	$5.219M	$4.873M
Total Long-Term Liabilities	$646.5K	$15.92K	$0.00
Total Liabilities	$5.887M	$5.235M	$4.873M
YoY Change	12.45%	-37.68%	-40.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$95.12M	-$86.78M	-$86.00M
YoY Change	9.61%	7.88%	9.46%
Common Stock	$96.60M	$90.44M	$88.45M
YoY Change	6.81%	3.78%	1.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K	$911.5K
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K	$33.33K
Shareholders Equity	$567.8K	$2.748M	$1.540M
YoY Change
Total Liabilities & Shareholders Equity	$6.375M	$7.962M	$6.401M
YoY Change	-19.93%	-44.53%	-59.04%

Cashflow Statement

Concept	2020 Q1	2019 Q1	2018 Q4
OPERATING ACTIVITIES
Net Income	-$1.600M	-$782.8K	$179.9K
YoY Change	104.43%	-58.23%	-110.05%
Depreciation, Depletion And Amortization	$37.22K	$26.05K	$26.17K
YoY Change	42.9%	-90.17%	-92.3%
Cash From Operating Activities	-$972.1K	-$220.2K	$329.5K
YoY Change	341.51%	-59.33%	-0.15%
INVESTING ACTIVITIES
Capital Expenditures	$7.138K	$8.104K	-$890.00
YoY Change	-11.92%	492.4%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$7.138K	-$8.104K	-$890.00
YoY Change	-11.92%	492.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$1.975M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	228.9K	2.225M	0.000
YoY Change	-89.71%
NET CHANGE
Cash From Operating Activities	-972.1K	-220.2K	329.5K
Cash From Investing Activities	-7.138K	-8.104K	-890.0
Cash From Financing Activities	228.9K	2.225M	0.000
Net Change In Cash	-750.3K	1.996M	328.6K
YoY Change	-137.58%	-467.83%	-0.42%
FREE CASH FLOW
Cash From Operating Activities	-$972.1K	-$220.2K	$329.5K
Capital Expenditures	$7.138K	$8.104K	-$890.00
Free Cash Flow	-$979.2K	-$228.3K	$330.4K
YoY Change	328.96%	-57.94%	0.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
CY2019Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
CY2020Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
CY2019Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
CY2020Q1	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod
CY2020Q1	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	1162607
CY2019Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	1057957
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05
CY2020Q1	mlss	Class Of Warrant Or Right Exerciable During Period ClassOfWarrantOrRightExerciableDuringPeriod	613446
CY2019Q1	mlss	Class Of Warrant Or Right Exerciable During Period ClassOfWarrantOrRightExerciableDuringPeriod	3249171
CY2020Q1	mlss	Class Of Warrant Or Right Exercisable Exercise Price ClassOfWarrantOrRightExercisableExercisePrice	0.50
CY2019Q1	mlss	Class Of Warrant Or Right Exercisable Exercise Price ClassOfWarrantOrRightExercisableExercisePrice	1.45
CY2020Q1	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	460725
CY2019Q1	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod
CY2020Q1	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.50
CY2019Q1	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
CY2019Q1	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749171
CY2020Q1	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
CY2019Q1	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.50
CY2020Q1	mlss	Common Stock Shares To Be Issued CommonStockSharesToBeIssued	90000
CY2020Q1	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	102768
CY2019Q1	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	337145
CY2020Q1	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	340476
CY2019Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	340476
CY2020Q1	mlss	Derivative Liability Assumed DerivativeLiabilityAssumed
CY2019Q1	mlss	Derivative Liability Assumed DerivativeLiabilityAssumed	406045
CY2020Q1	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	1008856
CY2020Q1	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	171046
CY2019Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	995603
CY2020Q1	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1612953
CY2019Q1	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-783631
CY2020Q1	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-76406
CY2019Q1	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	110215
CY2020Q1	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	65171
CY2019Q1	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	-118669
CY2020Q1	mlss	Noncash Portion Of Lease Expense NoncashPortionOfLeaseExpense	27627
CY2019Q1	mlss	Noncash Portion Of Lease Expense NoncashPortionOfLeaseExpense
CY2020Q1	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	706251
CY2019Q1	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	166292
CY2020Q1	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	-706251
CY2019Q1	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	-166292
CY2015Q2	mlss	Operating Leases Monthly Rent Expense OperatingLeasesMonthlyRentExpense	12522
CY2020Q1	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1
CY2019Q1	mlss	Reclassification Of Warrants And Shares To Be Issued ReclassificationOfWarrantsAndSharesToBeIssued	-406045
CY2019Q1	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock
CY2020Q1	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered
CY2019Q1	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered	7500
CY2020Q1	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	25000
CY2019Q1	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	40000
CY2020Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	171046
CY2019Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	61500
CY2020Q1	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	230362
CY2020Q1	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	182500
CY2019Q1	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	7000
CY2020Q1	mlss	Stock Issued To Board Of Directors StockIssuedToBoardOfDirectors
CY2019Q1	mlss	Stock Issued To Board Of Directors StockIssuedToBoardOfDirectors	61500
CY2020Q1	mlss	Warrants And Rights Exercisable Intrinsic Value WarrantsAndRightsExercisableIntrinsicValue	460085
CY2020Q1	mlss	Warrants And Rights Exercisable Weighted Average Remaining Term WarrantsAndRightsExercisableWeightedAverageRemainingTerm	P3Y310D
CY2019Q1	mlss	Warrants And Rights Exercisable Weighted Average Remaining Term WarrantsAndRightsExercisableWeightedAverageRemainingTerm	P2Y343D
CY2020Q1	mlss	Warrants And Rights Exercised Intrinsic Value WarrantsAndRightsExercisedIntrinsicValue	630389
CY2020Q1	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13253
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13252
CY2020Q1	us-gaap	Assets Assets	6374601
CY2019Q4	us-gaap	Assets Assets	6556289
CY2020Q1	us-gaap	Assets Current AssetsCurrent	5261182
CY2019Q4	us-gaap	Assets Current AssetsCurrent	6093148
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.55
CY2019Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.45
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1074171
CY2020Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	613446
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1500000
CY2019Q1	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue
CY2020Q1	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm
CY2019Q1	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P4Y310D
CY2019	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P4Y36D
CY2020Q1	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P3Y310D
CY2018	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P354D
CY2019Q1	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y343D
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1443742
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1379425
CY2020Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1389319
CY2019Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1358752
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1289538
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1710665
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	832329
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	775055
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	96553976
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	96082324
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30715
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56988
CY2020Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	775833
CY2019Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	710662
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	765975
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1516272
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1996271
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2739700
CY2020Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-750297
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2035826
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2019Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3249171
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49893534
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49410176
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49376843
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49376843
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	49893
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	49410
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	527250
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	618694
CY2019Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	23757603
CY2018Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2470565
CY2020Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	24665339
CY2019Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2807710
CY2020Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	11995
CY2019Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued
CY2020Q1	us-gaap	Depreciation Depreciation	23966
CY2019Q1	us-gaap	Depreciation Depreciation	12792
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37219
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26045
CY2019Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain	40000
CY2020Q1	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	0
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	64317
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-6772
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-421127
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-465710
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2020Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	41800
CY2020Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7279
CY2020Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	34521
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2252
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-369007
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-382260
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1612703
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-779166
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	9564
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	369007
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	382260
CY2020Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	40260
CY2020Q1	us-gaap	Gross Profit GrossProfit	1284136
CY2019Q1	us-gaap	Gross Profit GrossProfit	1297215
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	250
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4465
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	30567
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-263043
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	181410
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-50000
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	255426
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	182638
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-50000
CY2020Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges
CY2019Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-25398
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	102316
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-59760
CY2020Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-11755
CY2019Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-9523
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	165032
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	113
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1019
CY2020Q1	us-gaap	Inventory Net InventoryNet	1722825
CY2019Q4	us-gaap	Inventory Net InventoryNet	1620509
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	768000
CY2020Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	768000
CY2020Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	92859
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	99885
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10443
CY2020Q1	us-gaap	Liabilities Liabilities	5886772
CY2019Q4	us-gaap	Liabilities Liabilities	4927642
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6374601
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6556289
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5240233
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4927642
CY2020Q1	us-gaap	Minority Interest MinorityInterest	-80012
CY2019Q4	us-gaap	Minority Interest MinorityInterest	-67274
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	228920
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2224546
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7138
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8104
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-971079
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-220171
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-1600215
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-782752
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12738
CY2020Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
CY2020Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2020Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	2892742
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	2115396
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1608606
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-818181
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	677052
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	65034
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15924
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	612018
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	17264
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	39555
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	649425
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15924
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P146D
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35905
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4210
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2264
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7138
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8104
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	707011
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	519063
CY2020Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 14.7pt 0pt 0pt; text-align: left;"><div style="display: inline; font-weight: bold; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font: inherit;">3.</div>  </div><div style="display: inline; font-weight: bold;">Reclassifications</div></div> <div style=" margin: 0pt 14.7pt 0pt 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:14.7pt;margin-top:0pt;text-align:left;">Certain reclassification has been made to the <div style="display: inline; font-style: italic; font: inherit;">2019</div> financial statements to conform to the condensed consolidated <div style="display: inline; font-style: italic; font: inherit;">2020</div> financial statement presentation. These reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on net loss or cash flows as previously reported.</div></div></div></div></div>
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1974546
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2014Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000
CY2020Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	230362
CY2019Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-1612953
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-793195
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29961
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	44976
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	107480
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6346
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1811386
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1915909
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	43242
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95124512
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93524297
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	663009
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	166292
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2785262
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2109050
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	30715
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	56988
CY2020Q1	us-gaap	Share Price SharePrice	0.33
CY2020Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15012
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7500
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	567841
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1695921
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1628647
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	487829
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1528208
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2726502
CY2020Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:14.7pt;margin-top:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">4.</div>  Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:14.7pt;margin-top:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:14.7pt;margin-top:0pt;text-align:left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, and cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates.</div></div></div></div></div>
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	956012
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49730252
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40531762
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49730252
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40531762

Files In Submission

Name	View Source	Status
0001437749-20-011007-index-headers.html	Edgar Link	pending
0001437749-20-011007-index.html	Edgar Link	pending
0001437749-20-011007.txt	Edgar Link	pending
0001437749-20-011007-xbrl.zip	Edgar Link	pending
ex_181709.htm	Edgar Link	pending
ex_181710.htm	Edgar Link	pending
ex_181711.htm	Edgar Link	pending
ex_181714.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mlss-20200331.xml	Edgar Link	completed
mlss-20200331.xsd	Edgar Link	pending
mlss-20200331_cal.xml	Edgar Link	unprocessable
mlss-20200331_def.xml	Edgar Link	unprocessable
mlss-20200331_lab.xml	Edgar Link	unprocessable
mlss-20200331_pre.xml	Edgar Link	unprocessable
mlss20200331_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2020 Q1 Form 10-Q Financial Statement

#000143774920011007 Filed on May 15, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2020 Q1 Form 10-Q Financial Statement

#000143774920011007 Filed on May 15, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss